Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Sixty advanced breast cancer patients are planed to enrolled in this clinical trial. Forty
patients are enrolled into thalidomide plus chemotherapy group. Twenty patients are enrolled
into chemotherapy alone group. There is no restriction on chemotherapy regimen and lines.